RedHill Biopharma Ltd.
RDHLNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 15, 2026 close
- Market cap
- $1.70M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.44$2.14
- Volume (live)
- -
- Avg. volume (3M)
- 700.45K
RedHill Biopharma (RDHL) Stock Price & Financial Analysis
RedHill Biopharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.48 - $0.51 |
|---|---|
| 52-Week High | $2.14 |
| 52-Week Low | $0.44 |
| Open | $0.49 |
| Volume (last close) | 59.34K |
| Average Volume (3M) | 700.45K |
| Revenue (TTM) | 9.55M |
|---|---|
| Net Income (TTM) | -9.31M |
| Free Cash Flow (TTM) | -8.21M |
| EPS (TTM) | −$4.25 |
| Profit Margin | -97.52% |
| Operating Margin | -110.40% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 1.70M |
|---|---|
| Shares Outstanding | 3.16M |
| Price to Sales (P/S) | 0.18 |
| Price to Book (P/B) | -1.58 |
| EV/EBITDA | 0.30 |
| 50-Day MA | $0.59 |
|---|---|
| 200-Day MA | $0.86 |
| 1-Year Change | −68.21% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
RedHill Biopharma at a Glance
As of the Oct 15, 2026 close, RedHill Biopharma (RDHL) has a market capitalization of $1.70M. The stock trades at 0.2× sales. Over the trailing twelve months it lost $9.31M on revenue of $9.55M and burned $8.21M of free cash flow. Revenue fell 96.4% year over year.
As of its latest reported balance sheet, it holds $5.16M in cash and securities against $1.07M of debt, a net cash position of $4.09M.
RedHill Biopharma does not currently pay a dividend.
The share price is down 68.2% over the past year. At $0.50 (the Oct 15, 2026 close) it sits near the bottom of its 52-week range of $0.44 to $2.14, below its 200-day moving average of $0.86.
Frequently Asked Questions About RedHill Biopharma
What is the current stock price for RDHL?
As of the Oct 15, 2026 close, RDHL stock trades at $0.50. The 52-week range is $0.44–$2.14, with a day range of $0.48–$0.51.
What is the P/E ratio for RDHL?
The P/E ratio (Price-to-Earnings) for RDHL is shown in the Key Statistics section. This valuation metric helps compare RedHill Biopharma Ltd. to industry peers.
Does RDHL pay dividends?
RedHill Biopharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for RDHL?
Analyst ratings and recommendations for RDHL are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of RDHL?
As of the Oct 15, 2026 close, RedHill Biopharma's market capitalization is $1.6M, classifying it as a micro-cap company. RedHill Biopharma operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.